RoosterBio Inc has developed a Ready-to-Print (RTP) stem cell 3D bioprinter. This advancement in tissue engineering removes weeks from the current cellular bioprinting processes. This RTP provides significant quantities of high quality human mesenchymal stem cells (MCSs), which simplifies and accelerates the most complex and labor intensive aspects of bioprinting.
The medical application potential for 3D printing are numerous. From creating prosthetic limbs to creating entirely new organs, bioprinting is at the forefront of cutting edge medicine, but production challenges limit experimentation – and the swift development of practical applications. This advancement now allows physicians and tissue engineers to minimize time between research trials as well as minimize experimental variability.
This new product, which was unveiled at the Tissue Engineering and Regenerative Medicine International Society (TERMIS) World Congress in Boston, MA, will advance stem-cell-derived bioengineering solutions in the laboratory and the marketplace. To learn more about stem cells, and how families can bank their own valuable stem cells by recovering the very powerful dental pulp stem cells during routine dental procedures; such as wisdom teeth extractions or the during the loss of baby teeth, visit StemSave or call 877-783-6728 (877-StemSave) today.
To view the full article, click here.
The Future of Regenerative Medicine is Now™.